TMO in the 13F filings
Thermo Fisher Scientific Inc · CUSIP 883556102
- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 29 Oct 2025
- Managers listing it
- 32
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 25 listed it in both
- Shares listed
- 45,238,467
- combined, among listed positions
- Reported value
- $21.9bn
- combined, at the quarter end
Among the 95 comparable managers: 22 buyers (opened or added shares) and 13 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing TMO in Q3 2025
32 of 32 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 7,593,809 shares now+3,602,808
- Wellington Management Group LLPexisting position · 2,699,460 shares now+1,270,191
- T. Rowe Price Associates Incexisting position · 6,470,481 shares now+911,822
- Capital World Investorsexisting position · 10,285,145 shares now+706,572
- MFS Investment Managementexisting position · 2,936,998 shares now+594,218
Reductions
- Capital Research Global Investorsexisting position · 3,162,662 shares now-2,270,997
- Polen Capital Management LLCexisting position · 114,513 shares now-2,075,835
- Point72 Asset Management LPexisting position · 169,451 shares now-201,889
- Farallon Capital Management LLCexisting position · 1,258,241 shares now-125,000
- Neuberger Berman Group LLCexisting position · 867,616 shares now-54,072
New positions and exits
New (5)
Exited (3)
- Renaissance Technologies LLCwas $186m
- Two Sigma Advisers LPwas $159m
- Voloridge Investment Management LLCwas $122m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 19 | $8.8bn | n.a. | n.a. |
| Q3 2013 | 19 | $10.1bn | n.a. | n.a. |
| Q4 2013 | 19 | $12.6bn | n.a. | n.a. |
| Q1 2014 | 22 | $12.8bn | n.a. | n.a. |
| Q2 2014 | 22 | $12.9bn | n.a. | n.a. |
| Q3 2014 | 22 | $13.6bn | n.a. | n.a. |
| Q4 2014 | 30 | $14.7bn | n.a. | n.a. |
| Q1 2015 | 27 | $15.0bn | n.a. | n.a. |
| Q2 2015 | 27 | $14.1bn | n.a. | n.a. |
| Q3 2015 | 20 | $13.5bn | n.a. | n.a. |
| Q4 2015 | 21 | $15.4bn | n.a. | n.a. |
| Q1 2016 | 21 | $14.7bn | n.a. | n.a. |
| Q2 2016 | 20 | $14.9bn | n.a. | n.a. |
| Q3 2016 | 18 | $15.7bn | n.a. | n.a. |
| Q4 2016 | 31 | $13.2bn | n.a. | n.a. |
| Q1 2017 | 27 | $13.8bn | n.a. | n.a. |
| Q2 2017 | 29 | $15.7bn | n.a. | n.a. |
| Q3 2017 | 28 | $17.9bn | n.a. | n.a. |
| Q4 2017 | 20 | $18.2bn | n.a. | n.a. |
| Q1 2018 | 28 | $20.1bn | n.a. | n.a. |
| Q2 2018 | 27 | $19.9bn | n.a. | n.a. |
| Q3 2018 | 27 | $23.6bn | n.a. | n.a. |
| Q4 2018 | 30 | $21.6bn | n.a. | n.a. |
| Q1 2019 | 30 | $27.4bn | n.a. | n.a. |
| Q2 2019 | 33 | $28.8bn | n.a. | n.a. |
| Q3 2019 | 26 | $27.9bn | n.a. | n.a. |
| Q4 2019 | 26 | $30.3bn | n.a. | n.a. |
| Q1 2020 | 27 | $25.8bn | n.a. | n.a. |
| Q2 2020 | 29 | $32.6bn | n.a. | n.a. |
| Q3 2020 | 29 | $38.9bn | n.a. | n.a. |
| Q4 2020 | 33 | $39.2bn | n.a. | n.a. |
| Q1 2021 | 35 | $36.5bn | n.a. | n.a. |
| Q2 2021 | 33 | $38.3bn | n.a. | n.a. |
| Q3 2021 | 32 | $42.6bn | n.a. | n.a. |
| Q4 2021 | 38 | $50.1bn | n.a. | n.a. |
| Q1 2022 | 32 | $43.2bn | n.a. | n.a. |
| Q2 2022 | 33 | $38.9bn | n.a. | n.a. |
| Q3 2022 | 26 | $34.3bn | n.a. | n.a. |
| Q4 2022 | 29 | $37.0bn | n.a. | n.a. |
| Q1 2023 | 35 | $37.1bn | n.a. | n.a. |
| Q2 2023 | 39 | $33.5bn | n.a. | n.a. |
| Q3 2023 | 39 | $32.6bn | n.a. | n.a. |
| Q4 2023 | 41 | $32.7bn | 19 | 23 |
| Q1 2024 | 30 | $34.1bn | 14 | 18 |
| Q2 2024 | 38 | $30.6bn | 25 | 18 |
| Q3 2024 | 30 | $33.8bn | 12 | 19 |
| Q4 2024 | 36 | $27.6bn | 22 | 15 |
| Q1 2025 | 31 | $24.2bn | 12 | 22 |
| Q2 2025 | 39 | $18.8bn | 27 | 11 |
| Q3 2025 | 32 | $21.9bn | 22 | 13 |
| Q4 2025 | 32 | $29.9bn | 27 | 20 |
| Q1 2026 | 34 | $24.4bn | 23 | 23 |
| Q2 2026 | 36 | $26.4bn | 27 | 22 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TMO and LLY →TMO and JNJ →TMO and VRTX →Choose a stock to compare with TMO →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TMO, latest filings →Back to the 13F Explorer →